Label Changes for:
Zerit (stavudine) Powder for Oral Solution, 1mg/mL
February 2009
Changes have been made to the WARNINGS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- February 2009
| The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. |
|
Sections Modified |
Summary of Changes to Contraindications and Warnings |
|
WARNINGS
|
WARNINGS
ADVERSE REACTIONS
PATIENT PACKAGE INSERT
|
